Lidocaine/Tetracaine — Class II drug recall D-0252-2021
Terminated recall by Stanley Specialty Pharmacy Compounding and Wellness Center, reported 2021-02-17, distributed nationwide. Superpotent Drug. Lidocaine higher concentration than listed
| Recall number | D-0252-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Stanley Specialty Pharmacy Compounding and Wellness Center, Charlotte, NC, United States |
| Recall initiated | 2021-01-21 |
| Classified | 2021-02-10 |
| Reported by FDA | 2021-02-17 |
| Terminated | 2022-02-08 |
| Distributed | Nationwide (US) |
| Reason classes | potency |
| Lot numbers | 195789 |
| Expiration dates | 2021-04-17 |
Product
Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic ointment jar, Rx Only, Stanley Specialty Pharmacy 3120 Latrobe Dr. Suite 200 Charlotte, NC 28211
Reason for recall
Superpotent Drug. Lidocaine higher concentration than listed
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0252-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.